Greedy Insider · Filing
VRXA · Buy · Gruninger Marc
Gruninger Marc (Director) bought 867 shares of Veraxa Biotech AG - Post de-SPAC (VRXA) at $0.98, about $850, on Oct 27, 2026, filed with the SEC on Oct 29, 2026.
Greediness Score 35 · Weak · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001829126-26-011778